Advertisement

Topics

Nuclear Medicine - Biotech, Pharma and Life Science Channel

04:21 EDT 23rd August 2017 | BioPortfolio

Nuclear medicine is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease.

In nuclear medicine procedures, radionuclides are combined with other elements to form chemical compounds, or else combined with existing pharmaceutical compounds, to form radiopharmaceuticals. These radiopharmaceuticals, once administered to the patient, can localize to specific organs or cellular receptors.

This property of radiopharmaceuticals allows nuclear medicine the ability to image the extent of a disease process in the body, based on the cellular function and physiology, rather than relying on physical changes in the tissue anatomy. In some diseases, nuclear medicine studies can identify medical problems at an earlier stage than other diagnostic tests. 

Treatment of diseased tissue, based on metabolism or uptake or binding of a particular ligand, may also be accomplished, similar to other areas of pharmacology. However, the treatment effects of radiopharmaceuticals rely on the tissue-destructive power of short-range ionizing radiation.

In the future, nuclear medicine may provide added impetus to the field known as molecular medicine. As understanding of biological processes in the cells of living organisms expands, specific probes can be developed to allow visualization, characterization, and quantification of biologic processes at the cellular and subcellular levels.[

Source: Wikipedia

 

News Articles [68 Associated News Articles listed on BioPortfolio]

Nuclear Medicine/Radiopharmaceutical Global Market Forecast To 2022 [Report Updated: 24032016] Prices from USD $4500

Way back to the history, over the past 50 years nuclear medicine sector has displayed a strong link between investments in chemistry and development of radionuclide's and radiolabeled compounds. This ...

ASTRO supports U.S. Nuclear Regulatory Commission final rule

ARLINGTON, Va., Aug. 18, 2017 /PRNewswire-USNewswire/ -- The American Society for Radiation Oncology (ASTRO) applauds the United States Nuclear Regulatory Commission (NRC) for yesterday's announc...

Lantheus Medical Imaging Inc Strategic SWOT Analysis Review [Report Updated: 27072017] Prices from USD $125

Lantheus Medical Imaging Inc Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a d...

Navidea Biopharmaceuticals Inc NAVB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27072017] Prices from USD $250

SummaryNavidea Biopharmaceuticals Inc Navidea is a precision medicine company that focuses on the development and commercialization of radiopharmaceutical agents and precision diagnostics. Its key pro...

Lantheus Medical Imaging Inc Medical Equipment Deals and Alliances Profile [Report Updated: 17072017] Prices from USD $250

SummaryLantheus Medical Imaging Inc Lantheus Medical, a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of co...

MRI Assisted Radiosurgery (MARS) Utilizing C4 Imaging's Sirius™ Positive-Signal MRI Marker is a Cost-Effective Option for the Treatment of Prostate Cancer

HOUSTON, Aug. 7, 2017 /PRNewswire/ -- C4 Imaging LLC announced today that the American Brachytherapy Society's journal, Brachytherapy, has published a special issue focused on MRI-based prostate ...

CamelIDS NV Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25072017] Prices from USD $250

SummaryCamelIDS NV CamelIDS is a biotechnology company which develops targeted radionuclide therapeutic solutions for the treatment of cancer. The company focuses on developing its lead compound radio...

Global Stable Isotopes Market Data Survey Report 2025 [Report Updated: 26072017] Prices from USD $1500

SummaryStable nuclides are nuclides that are not radioactive and so unlike radionuclides do not spontaneously undergo radioactive decay. When such nuclides are referred to in relation to specific elem...

Cyclopharm Ltd CYC Medical Equipment Deals and Alliances Profile [Report Updated: 11072017] Prices from USD $250

SummaryCyclopharm Ltd Cyclopharm is a radiopharmaceutical company that manufactures medical and healthcare equipment and components in the nuclear medicine business. The company's products include Tec...

Navidea Biopharmaceuticals Inc NAVB Medical Equipment Deals and Alliances Profile [Report Updated: 17072017] Prices from USD $250

SummaryNavidea Biopharmaceuticals Inc Navidea is a precision medicine company that focuses on the development and commercialization of radiopharmaceutical agents and precision diagnostics. Its key pro...

Events [0 Results]

None

Companies [9 Associated Companies listed on BioPortfolio]

Navidea Biopharmaceuticals

Navidea Biopharmaceuticals (NYSE Amex: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agent...

Advanced Medical Isotope Corporation

Advanced Medical Isotope Corporation (ADMD) is a late stage development company engaged in the development of brachytherapy devices for therapeutic applications. AMIC's focus is o...

Lantheus Holdings, Inc.

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc. (“LMI”), which is a global leader in developing, manufacturing, selling and distributing ...

Cambridge Isotope Laboratories, Inc.

Cambridge Isotope Laboratories, Inc. (www.isotope.com) is the world's premier supplier of stable isotopes and stable isotope labeled compounds for research applications in structu...

Navidea Biopharmaceuticals Inc.

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical ...

Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical...

Neoprobe Corporation and Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals (NYSE Amex: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agent...

KineMed, Inc.

KineMed, Inc. ("KineMed" or the "Company") is a drug discovery and development company employing its proprietary translational medicine technology (AquaTag™ and KineMarkerâ...

Symbiotic Research Services

SR is a contract research organization (CRO) which is licensed to conduct research with radio labeled C-14 materials. SR has been inspected by the US-EPA and the NJ-DEP Division o...

Clinical Trials [356 Associated Clinical Trials listed on BioPortfolio]

Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer

This is a multicentric prospective non-randomized phase II trial, with two independent arms: one for patients with RAS mutation and one for patients with BRAFV600E mutation.

PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection

Background: HIV affects millions of people. The disease may "hide" in the brain, even in people with well-controlled HIV without cancer. Then it may "wake up" and continue. The drug ...

Predictors of AAA Expansion and/or Rupture

Eligible subjects in this study will have either a known abdominal aortic aneurysm (AAA) or because they do not have an AAA (control group). The purpose of this research study is to furth...

Observation and Evaluation of Short-term Curative Effect of Local Advanced Cervical Cancer Treated With Particle Radiotherapy Versus Neoadjuvant Chemotherapy

Locally advanced cervical cancer (LACC) refers to the clinically cervical visible lesion with a diameter of > 4 cm, which has been considered as a high risk of early cervical cancer for a ...

Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection

68Ga-PSMA is a radiopharmaceutical used with PET imaging for the detection of prostate cancer under a compassionate IND in patients who have presented with biochemical failure. In this stu...

Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer

This is an open-label single arm clinical trial, plan to enroll approximately a total of 62 evaluable subjects. According to the estimated missing rate 15%, the sample size in this study i...

Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Background: Chronic lymphocytic leukemia (CLL) is a cancer of white blood cells. It is also called small lymphocytic lymphoma (SLL). It causes tiredness, night sweats, weight loss, swolle...

Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer

The goal of the study is to evaluate a new imaging test that may allows the investigators to predict the uptake of radioactive iodine by thyroid cancer faster than the current standard and...

Brain Dopaminergic Signaling in Opioid Use Disorders

Background: The chemical messenger dopamine carries signals between brain cells. It may affect addiction. Heavy use of pain medicines called opioids may decrease the amount of dopamine ...

Tau PET Imaging in the NACC Study Cohort

The purpose of this study is to measure the amount of a protein in the brain known as tau using an imaging procedure called Positron Emission Tomography (PET/CT). 18F-AV-1451 is a speciali...

PubMed Articles [251 Associated PubMed Articles listed on BioPortfolio]

Accuracy of (177)Lu activity quantification in SPECT imaging: a phantom study.

The aim of the study is to assess accuracy of activity quantification of (177)Lu studies performed according to recommendations provided by the committee on Medical Internal Radiation Dose (MIRD) pamp...

Investigation of Natural Radioactivity in a Monazite Processing Plant in Japan.

Monazite is a naturally occurring radioactive material that is processed for use in a variety of domestic applications. At present, there is little information available on potential radiation doses e...

Body Surface Contamination Levels of Residents under Different Evacuation Scenarios after the Fukushima Daiichi Nuclear Power Plant Accident.

Body surface contamination levels should be correlated with inhaled actual thyroid doses during evacuation following the Fukushima Daiichi nuclear power plant (FDNPP) accident. Evacuees and residents ...

Assessment of the announced North Korean nuclear test using long-range atmospheric transport and dispersion modelling.

On 6 January 2016, the Democratic People's Republic of Korea announced to have conducted its fourth nuclear test. Analysis of the corresponding seismic waves from the Punggye-ri nuclear test site show...

Delayed risk stratification system in pT1aN0/Nx DTC patients treated without radioactive iodine.

A delayed risk stratification (DRS) system by Momesso et al. was accepted by the American Thyroid Association as a diagnostic tool for the risk stratification of unfavorable clinical outcomes and to m...

Molecular Imaging of P-glycoprotein in Chemoresistant Tumors using a Dual-Modality PET/Fluorescence Probe.

Overexpression of P-glycoprotein (Pgp) has been considered a primary cause for multidrug resistance in a variety of cancers for three decades. However, clinical translation of Pgp targeted therapeutic...

Nine New Triterpene Glycosides, Magnumosides A₁-A₄, B₁, B₂, C₁, C₂ and C₄, from the Vietnamese Sea Cucumber Neothyonidium (=Massinium) magnum: Structures and Activities against Tumor Cells Independently and in Synergy with Radioactive Irradiation.

Nine new sulfated triterpene glycosides, magnumosides A₁ (1), A₂ (2), A₃ (3), A₄ (4), B₁ (5), B₂ (6), C₁ (7), C₂ (8) and C₄ (9) as well as a known colochiroside B₂ (10) have been i...

Removal of soluble strontium into biogenic carbonate minerals from a highly saline solution using halophilic bacterium, Bacillus sp. TK2d.

Radioactive strontium ((90)Sr) leaked into saline environments, including the ocean, from the Fukushima Daiichi Nuclear Power Plant after a nuclear accident. Since the removal of (90)Sr using general ...

Imaging Active Infection in vivo Using D-Amino Acid Derived PET Radiotracers.

Occult bacterial infections represent a worldwide health problem. Differentiating active bacterial infection from sterile inflammation can be difficult using current imaging tools. Present clinically ...

Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial.

This study aimed to examine the radioprotective effect of vitamin E on salivary glands after radioactive iodine (I) therapy in patients with differentiated thyroid cancer.

Videos

None available.

Medical and Biotech [MESH] Definitions

Radioactive substances which act as pollutants. They include chemicals whose radiation is released via radioactive waste, nuclear accidents, fallout from nuclear explosions, and the like.

Uncontrolled release of radioactive material from its containment. This either threatens to, or does, cause exposure to a radioactive hazard. Such an incident may occur accidentally or deliberately.

Contamination of air with radioactive substances.

Liquid, solid, or gaseous waste resulting from mining of radioactive ore, production of reactor fuel materials, reactor operation, processing of irradiated reactor fuels, and related operations, and from use of radioactive materials in research, industry, and medicine. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)

A nontoxic radiopharmaceutical that is used in the diagnostic imaging of the renal cortex.

Quick Search
Advertisement
 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

review and buy Nuclear Medicine market research data and corporate reports here

Channels Quicklinks